PUBLIC CONTRACT · 2012
61004613- Medicamentos para o Sangue
- Contract value
- €625,464.00
- Signed on
- 30 November 2012
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 726379PUBLISHED SUBJECT
Aquisição de 300 SER de Darbepoetina alfa 150 μg/0.3 ml Sol inj Ser 0.3 ml IV SC, 300 SER de Darbepoetina alfa 300 μg/0.6 ml Sol inj Ser 0.6 ml IV SC, 800 SER de Darbepoetina alfa 500 μg/1 ml Sol inj Ser 1 ml IV SC e 200 SER de Darbepoetina alfa 80 μg/0.4 ml Sol inj Ser 0.4 ml IV SC.
Parties involved
- Place of performance
- Portugal, Faro, Portimão
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- AMGEN BIOFARMACÊUTICA, LDA · Tax ID 502942959
Values and timeline
- Contract price
- €625,464.00
- Procedure base price
- €792,717.65
- Total effective price
- €69,433.87
- Publication date
- 22 February 2013
- Award date
- 17 October 2012
- Signing date
- 30 November 2012
- Performance period
- 365 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Not stated
- CPV code
- 33620000-2 - Medicamentos para o sangue, para os órgãos hematopoiéticos e para o aparelho cardiovascular
- Legal basis
- Artigo 24.º, n.º 1, alínea e) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL 18/2008)
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 581617
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.